Lavipharm SA. announces that, according to the article 292 paragraph 4 of the Athens Stock Exchange Regulation, the annual analyst presentation took place today, Monday, June 25th at the Company's premises. The presentation is available for the information of the Investors Community on the website of both Lavipharm and the Athens Stock Exchange.
See the Analyst Presentation